BridgeMD
Tests treatment safety and results for Bladder Cancer
Official title Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
ClinicalTrials.gov ID: NCT03108196
What this study is testing
- What it's testing
- Bladder cancer is a common malignant tumor of the urinary system, radical resection plus urinary diversion is the first choice of treatment for muscle invasive bladder cancer. Urinary diversion of surgical options related to patient' survival and quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Bladder carcinoma in situ, include CIS and T1G3 tumor, muscle invasive bladder cancer（T2/T3N0-1M0）
- Recurrent bladder cancer
- Other conditions that have been approved by a urologist for indications for new bladder surgery
- Had been received intravesical chemotherapy, intra-arterial infusion chemotherapy or systemic chemotherapy in the past.
- Voluntarily signed the informed consent -
You likely can't join if
- Preoperative serum creatinine more than 2.26mg/dl（Or 200μmol/L）
- Cancer invaded urethral (confirmed by the pathology)
- Non - bladder cancer patients underwent neobladder
- A history of other malignant tumors within five years
- Ileum / sigmoid chronic inflammation, like ulcerative colitis or intestinal tuberculosis, and so on.
- Other conditions that have been approved by a urologist for not suitable for new bladder surgery \-
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.